Please provide your email address to receive an email when new articles are posted on . Keratoconus is a noninflammatory, progressive, bilateral ectatic corneal disease with corneal stromal thinning ...

Please provide your email address to receive an email when new articles are posted on . Glaukos and iVeena Delivery Systems have entered into a strategic licensing agreement that grants Glaukos an ...

Two surgical procedures have been described for ICRS implantation: the mechanical method and the femtolaser method. The use of femtolaser for ICRS tunnel creation was widely accepted after FDA ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Epion Therapeutics (Epion) announced the commencement of its Phase 3 Apricity trials for EpiSmart™, the company’s minimally-invasive keratoconus therapy. This marks ...

On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...

Keratoconus is a progressive corneal ectasia characterised by stromal thinning, anterior protrusion and irregular astigmatism leading to visual impairment. Corneal collagen crosslinking (CXL) has ...

SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems Inc. (“iVeena”), a clinical stage biopharmaceutical company with developmental products in keratoconus and pediatric myopia, has entered into a ...

Keratoconus is a progressive, noninflammatory corneal disorder that causes corneal thinning and irregularity, resulting in impaired vision. It typically begins in adolescence and progresses slowly ...

Epi-on Treatment Demonstrated the Ability to Halt or Reduce the Progression of Keratoconus versus Observed Disease Progression in a Placebo-Control Arm Data Suggest Epi-on Has the Potential to Provide ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Keratoconus is a progressive eye condition that affects the shape and clarity of the cornea, often beginning in the teenage years or early adulthood. As the cornea thins and bulges into a cone-like ...